Drug Trial Radar · NCT05625399
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
Last checked: Nov 19, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
579
Actual
Start
Mar 6, 2023
Primary completion
Aug 4, 2025
Study completion Nov 18, 2027
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- Collaborators
- Halozyme Therapeutics
- First posted
- Nov 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate that the study drug exposure level of the nivolumab + relatlimab FDC subcutaneous (SC) formulation is not worse than nivolumab + relatlimab FDC intravenous (IV) administration in participants with previously untreated metastatic or unresectable melanoma.
Conditions
- Melanoma
Interventions
Nivolumab + RelatlimabDrug
Specified dose on specified days
rHuPH20Drug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adjusted Time-Averaged Nivolumab Serum Concentration Over the First 28 Days (Cavgd28-Nivo) on Natural Logarithmic ScaleTime frame: Pre-dose (Day 1 to Day 28)
- Adjusted Time-Averaged Relatlimab Serum Concentration Over the First 28 Days (Cavgd28-Rela) on Natural Logarithmic ScaleTime frame: Pre-dose (Day 1 to Day 28)
- Adjusted Trough Nivolumab Serum Concentration at Steady-State (Cminss-Nivo) on Natural Logarithmic ScaleTime frame: Pre-dose (Day 1 to Day 28)
- Adjusted Trough Relatlimab Serum Concentration at Steady-State (Cminss-Rela) on Natural Logarithmic ScaleTime frame: Pre-dose (Day 1 to Day 28)
Locations
149 sites in 19 countries. Site status is shown where the registry gives one.
Local Institution - 0125
Phoenix, Arizona
Local Institution - 0189
Springdale, Arkansas
Local Institution - 0098
Los Angeles, California
Local Institution - 0093
Orange, California
Local Institution - 0123
Stanford, California
Local Institution - 0113
Englewood, Colorado
Local Institution - 0114
Jacksonville, Florida
Local Institution - 0146
Baltimore, Maryland
Local Institution - 0071
Rochester, Minnesota
Local Institution - 0013
Omaha, Nebraska
Local Institution - 0169
Cleveland, Ohio
Local Institution - 0139
Easton, Pennsylvania
Local Institution - 0124
Philadelphia, Pennsylvania
Local Institution - 0122
Murray, Utah
Local Institution - 0115
Fairfax, Virginia
Local Institution - 0050
Coffs Harbour, New South Wales, Australia
Local Institution - 0175
Orange, New South Wales, Australia
Local Institution - 0172
Port Macquarie, New South Wales, Australia
Local Institution - 0118
Wagga Wagga, New South Wales, Australia
Local Institution - 0184
Waratah, New South Wales, Australia
Local Institution - 0033
Westmead, New South Wales, Australia
Local Institution - 0055
Wollstonecraft, New South Wales, Australia
Local Institution - 0090
Birtinya, Queensland, Australia
Local Institution - 0008
Bendigo, Victoria, Australia
Local Institution - 0059
Box Hill, Victoria, Australia
Local Institution - 0154
Heidelberg, Victoria, Australia
Local Institution - 0030
Melbourne, Victoria, Australia
Local Institution - 0109
Traralgon, Victoria, Australia
Local Institution - 0106
Nedlands, Western Australia, Australia
Local Institution - 0161
Nedlands, Western Australia, Australia
Local Institution - 0027
Graz, Austria
Local Institution - 0029
Salzburg, Austria
Local Institution - 0168
Sankt Pölten, Austria
Local Institution - 0037
Vienna, Austria
Local Institution - 0072
Brussels, Belgium
Local Institution - 0078
Charleroi, Belgium
Local Institution - 0016
Liège, Belgium
Local Institution - 0177
Fortaleza, Ceará, Brazil
Local Institution - 0180
Vitória, Espírito Santo, Brazil
Local Institution - 0107
Belo Horizonte, Minas Gerais, Brazil
Showing 40 of 149 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.